Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $0.71 in the prior trading day, AEON Biopharma Inc (AMEX: AEON) closed at $0.75, up 6.36%. In other words, the price has increased by $6.36 from its previous closing price. On the day, 0.56 million shares were traded.
Ratios:
Our goal is to gain a better understanding of AEON by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 21 ’25 when FISCHER JOST bought 60,000 shares for $0.49 per share. The transaction valued at 29,250 led to the insider holds 266,785 shares of the business.
FISCHER JOST bought 60,000 shares of AEON for $30,360 on May 20 ’25. The Director now owns 206,785 shares after completing the transaction at $0.51 per share. On May 19 ’25, another insider, FISCHER JOST, who serves as the Director of the company, bought 50,000 shares for $0.50 each. As a result, the insider paid 24,940 and bolstered with 146,785 shares of the company.
Valuation Measures:
As of this moment, AEON’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.00.
Stock Price History:
Over the past 52 weeks, AEON has reached a high of $269.28, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is 31.05%, while the 200-Day Moving Average is calculated to be -97.12%.
Shares Statistics:
A total of 10.54M shares are outstanding, with a floating share count of 9.43M. Insiders hold about 16.57% of the company’s shares, while institutions hold 13.50% stake in the company.
